The sixth edition of EvaluatePharma's World Preview brings together many of our analyses to provide a top level insight, from the world's financial market, into the expected performance of the industry between now and 2018.
Based on EvaluatePharma's coverage of the world's leading 4,000 pharmaceutical and biotech companies, the World Preview highlights trends in prescription drug sales, patent risk, R&D spend, global brand sales and market performance by therapy area. Also included in the report is a brief review of 2012 performance - view the report infographic (PDF).
Key highlights in the World Preview 2013, Outlook to 2018 include:
Every year we publish our 44+ page World Preview report and make it available to industry free of charge.
To download you own complimentary copy of the latest edition, we only ask that you confirm your details on the short form opposite so that we may better understand our growing readership. Many thanks.